Background and Objectives Identification of biomarkers for early diagnosis and treatment
response would be beneficial for patients with early rheumatoid arthritis (ERA) to prevent …

Background Identification of parameters for early diagnosis and treatment response would
be beneficial for patients with early rheumatoid arthritis (ERA) to prevent ongoing joint …

Background MiRs are involved as fine tuning regulators of gene expression in crucial
cellular processes and their dysregulation has been described in many diseases …

Background We have recently demonstrated that miR-223 is up-regulated in peripheral
blood and synovial CD3+ T lymphocytes (TL) from Rheumatoid Arthritis (RA) patients …

Background Studies have shown a beneficial effect of early treatment on clinical outcome
and reduction in joint damage in patients with rheumatoid arthritis (RA). MiRNAs are stably …

Background Rheumatoid Arthritis (RA) is a systemic autoimmune disorder characterized by
chronic synovitis and progressive joint destruction. MicroRNAs (miRNAs) are small non …

Background: Micro-RNAs (miRNAs) are an endogenous small, single-stranded, non-coding
RNAs with a 18-25 nucleotide long and have been reported as a potential extracellular …

Background Rheumatoid arthritis (RA) is associated with altered miRNA expression profile
in peripheral blood, synovial fluid and synovial membrane. There are several reports on the …

Background MicroRNAs (miRNAs) comprise a class of small, non-coding RNAs that serve
as important negative regulators of gene expression at posttranscriptional level. Studies …

Background IL-17 is a proinflammatory cytokine, which overproduction promotes the
autoimmune reaction in rheumatoid arthritis (RA). Recent studies have shown that IL-17 …